Tong Jeffrey K
SEC-identified person · CIK 1479701 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Septerna, Inc. SEPN | Director | filed 2024 - 2026 |
| Maze Therapeutics, Inc. MAZE | Director | filed 2025 - 2025 |
| Rapport Therapeutics, Inc. RAPP | Director | filed 2024 - 2024 |
| Nurix Therapeutics, Inc. NRIX | Director | filed 2020 - 2021 |
| Infinity Pharmaceuticals, INC. INFI | VP, Cor. & Product Development | filed 2010 - 2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.